Altered Expression of Endogenous Soluble Vascular Endothelial Growth Factor Receptor-2 Is Involved in the Progression of Esophageal Squamous Cell Carcinoma

Endogenous soluble vascular endothelial growth factor receptor-2 (esVEGFR-2), a new splicing variant of VEGFR-2, was shown to be the first endogenous specific inhibitor of lymphatic vessel growth. The expression of esVEGFR-2 and its clinicopathological roles in esophageal squamous cell carcinoma (ES...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wu, Zhi-Yong, Chen, Tao, Zhao, Qing, Huang, Jian-Hao, Chen, Jie-Xin, Zheng, Chun-Peng, Xu, Xiu-E, Wu, Jian-Yi, Xu, Li-Yan, Li, En-Min
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2013
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3636701/
https://ncbi.nlm.nih.gov/pubmed/23392734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1369/0022155413480181
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars